Prokarium
Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.
6
Funding Rounds
$86.6m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ro*** Cr********* | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Te* Fj******* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Prokarium has raised a total of $86.6m in funding over 6 rounds.
Key Insights:
- Prokarium February 2023 Series B Funding Round: $30m
- Prokarium Series B round, October 2020: $21m
- Prokarium , October 2019: $5.6m
- Prokarium , February 2018: $10m
- Prokarium Limited , February 2018: $10m
- Prokarium funding round, February 26, 2018: $10m
Prokarium February 2023 Series B Funding Round
$30m
Prokarium Series B round, October 2020
$21m
Prokarium , October 2019
$5.6m
Prokarium , February 2018
$10m
Prokarium Limited , February 2018
$10m
Prokarium funding round, February 26, 2018
$10m
Industries
Prokarium is active in the following industries: